• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤梗死的 livedoid 血管病变 - 目前的诊断和治疗方面。

Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.

机构信息

Department of Dermatology, University Hospital Münster, Germany.

出版信息

J Dtsch Dermatol Ges. 2013 May;11(5):407-10. doi: 10.1111/ddg.12064. Epub 2013 Feb 26.

DOI:10.1111/ddg.12064
PMID:23437985
Abstract

Livedoid vasculopathy is a rare, chronic, recurrent disease of the cutaneous microcirculation. Its typical clinical manifestation is a triad which consists of livedo racemosa of the skin, episodic painful ulcerations of the distal aspects of the legs and a healing process leaving small porcelain-white scars called atrophie blanche. As an important result of recent research, livedoid vasculopathy has been defined as a coagulation disorder classified as a vasculopathy different from inflammatory vasculitis. This differentiation adds to the current pathophysiologic understanding and supports the therapeutic rationale with respect to the use of new systemic anticoagulants. The prevention of irreversible residual scarring and the improvement of patientsí quality of life are the main goals in treating cutaneous infarction and require early and consequent treatment. This article presents current knowledge on diagnosing this rare disease and offers practical guidance on its therapy.

摘要

皮肤白细胞破碎性血管炎是一种罕见的、慢性的、复发性皮肤微循环疾病。其典型临床表现为三联征,包括皮肤匐行性青斑、小腿远端间歇性疼痛性溃疡和愈合过程中遗留的小瓷白色瘢痕(萎缩性白色瘢痕)。作为最近研究的重要结果,皮肤白细胞破碎性血管炎已被定义为一种凝血障碍,归类为不同于炎症性血管炎的血管病。这种分化增加了目前对病理生理学的理解,并支持了使用新型全身性抗凝剂的治疗原理。预防不可逆转的残余瘢痕形成和改善患者的生活质量是治疗皮肤梗死的主要目标,需要早期和持续的治疗。本文介绍了诊断这种罕见疾病的最新知识,并提供了其实践治疗的指导。

相似文献

1
Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.皮肤梗死的 livedoid 血管病变 - 目前的诊断和治疗方面。
J Dtsch Dermatol Ges. 2013 May;11(5):407-10. doi: 10.1111/ddg.12064. Epub 2013 Feb 26.
2
[Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].[萎缩性硬化性苔藓样皮炎。皮肤梗死的发病机制、诊断与治疗]
Hautarzt. 2011 Aug;62(8):627-34; quiz 635. doi: 10.1007/s00105-011-2172-3.
3
Livedoid vasculopathy - a thrombotic disease.萎缩性硬化性苔藓样血管病——一种血栓性疾病。
Vasa. 2013 Sep;42(5):317-22. doi: 10.1024/0301-1526/a000296.
4
The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.真皮层血管病变的管理侧重于直接口服抗凝剂(DOACs):4 例利伐沙班成功治疗的病例报告。
Int J Dermatol. 2018 Jun;57(6):732-741. doi: 10.1111/ijd.13997. Epub 2018 Apr 16.
5
Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.与皮肤婴儿血管瘤 involutional 期相关的单侧类紫癜性血管病:与凝血障碍的关联
Int J Low Extrem Wounds. 2013 Dec;12(4):306-9. doi: 10.1177/1534734613502049. Epub 2013 Sep 16.
6
Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.皮肤白细胞碎裂性血管病:应用改良 Delphi 法的深入分析。
J Am Acad Dermatol. 2013 Dec;69(6):1033-1042.e1. doi: 10.1016/j.jaad.2013.07.019. Epub 2013 Sep 9.
7
Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.新型低剂量口服抗凝剂治疗顽固性类脂质渐进性坏死性血管病的疗效
BMJ Case Rep. 2017 Jul 24;2017:bcr-2017-219943. doi: 10.1136/bcr-2017-219943.
8
Livedoid vasculopathy - A diagnostic and therapeutic challenge.萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.
9
Livedoid vasculopathy as a coagulation disorder.皮肤白细胞碎裂性血管病作为一种凝血障碍。
Autoimmun Rev. 2011 Apr;10(6):353-60. doi: 10.1016/j.autrev.2010.11.008. Epub 2010 Dec 22.
10
Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.成功用小剂量华法林治疗类脂蛋白血管病伴发周围神经病 1 例
J Dermatol. 2010 Jan;37(1):98-101. doi: 10.1111/j.1346-8138.2009.00754.x.

引用本文的文献

1
Effective Treatment of Livedoid Vasculopathy With Oral Tofacitinib.口服托法替布有效治疗类癌性血管病
Clin Case Rep. 2025 May 28;13(6):e70536. doi: 10.1002/ccr3.70536. eCollection 2025 Jun.
2
Vasculitides and occluding vasculopathies, challenges in recognizing histopathological patterns, and their solutions.血管炎和闭塞性血管病、识别组织病理学模式的挑战及其解决方案。
Front Med (Lausanne). 2023 Feb 1;9:994450. doi: 10.3389/fmed.2022.994450. eCollection 2022.
3
A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.
关于萎缩性硬化性苔藓样血管病的发病机制、关联因素、临床发现及治疗的全面综述。
Front Med (Lausanne). 2022 Dec 8;9:993515. doi: 10.3389/fmed.2022.993515. eCollection 2022.
4
Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review.皮肤白细胞碎裂性血管病伴发周围神经病:55 例中国患者的回顾性队列研究及文献复习。
Int Wound J. 2023 May;20(5):1498-1505. doi: 10.1111/iwj.14004. Epub 2022 Nov 4.
5
Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review.利伐沙班与免疫球蛋白疗法治疗类脂质渐进性坏死性血管病的疗效比较:一项系统评价
Cureus. 2022 Aug 27;14(8):e28485. doi: 10.7759/cureus.28485. eCollection 2022 Aug.
6
A case of a recalcitrant painful skin ulceration.一例顽固性疼痛性皮肤溃疡病例。
Int J Dermatol. 2023 Feb;62(2):199-201. doi: 10.1111/ijd.16416. Epub 2022 Aug 30.
7
Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level.静脉注射免疫球蛋白治疗皮肤白细胞碎裂性血管炎:临床疗效和患者活动水平的回顾性观察。
J Cutan Med Surg. 2021 Sep;25(5):504-510. doi: 10.1177/12034754211003525. Epub 2021 Mar 28.
8
Juvenile primary Sjogren's syndrome with cutaneous involvement.儿童原发性干燥综合征伴皮肤受累。
Clin Rheumatol. 2021 Sep;40(9):3687-3694. doi: 10.1007/s10067-021-05656-0. Epub 2021 Mar 12.
9
Livedoid vasculopathy and its association with genetic variants: A systematic review.真皮白细胞破碎性血管病及其与遗传变异的关联:系统评价。
Int Wound J. 2021 Oct;18(5):616-625. doi: 10.1111/iwj.13563. Epub 2021 Mar 8.
10
Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.纤溶酶原激活物抑制剂-1:类脂质渐进性坏死发病中的一个潜在病因学角色。
Int Wound J. 2020 Dec;17(6):1902-1908. doi: 10.1111/iwj.13480. Epub 2020 Oct 11.